| Active Ingredient | GRANISETRON |
| Therapeutic Class | ANTIEMETICS |
| Indications |
Management of nausea and vomiting induced by cytotoxic chemotherapy andradiotherapy, treatment of postoperative nausea and vomiting. |
| Caution | Constipation; diarrhoea; headache; insomnia. |
| Dose Range |
Adult: 1 mg, dose to be diluted to 5 mL and given over 30 seconds; maximum 3 mg p er day . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |